A faster, consistent way to read flow cytometry data
Read full article about our AI approach
Asudes core benefits
Speed up flow cytometry analysis to make faster, smarter clinical decisions.
Get reliable results with precise data analysis you can trust every time.
Ensure repeatable outcomes with standardized and dependable processes.
Save time and reduce effort. Let AI simplify your flow cytometry workflow.
Achieve high-quality results with protocols designed for consistency and comparability.
Meet Asudes powered by Eclipse
Your reliable tool for smarter flow cytometry
How does Asudes turn complex flow cytometry data into clear insights?
Asudes filters out normal cells and shows only the abnormal populations. This removes the need for long manual gating and simplifies interpretation.
Results appear in minutes, even for large or high-dimensional datasets.
How does the Asudes platform work?
Asudes uses the deterministic ECLIPSE algorithm to process flow cytometry data in the cloud. It removes normal events and highlights the abnormal ones in a simple 2D view.
The platform is instrument-agnostic and works across different panels without retraining. It is designed for labs, clinics, and research teams that need fast, reproducible results.
What makes Asudes different from other solutions?
The platform uses a clinically validated, deterministic model that provides the same result every time, independent of user or instrument.
It handles large datasets without downsampling and supports both clinical and research workflows through a clean, intuitive interface.
How does Asudes support clinical and research teams?
Asudes speeds up interpretation, reduces manual workload, and gives teams clearer insight into rare or abnormal cell populations.
It supports MRD, POCT, infection screening, and high-dimensional research by delivering fast, reproducible results suitable for both routine and advanced analysis.
How the ECLIPSE algorithm works
1. Build a control model using SCA
Healthy samples are processed using Simultaneous Component Analysis (SCA). This creates a multi-sample control model that reflects normal cell behavior across individuals. This serves as the reference baseline.
2. Compare patient data to the control model
A patient’s sample is projected onto the same model. Cells that behave similarly to the normal controls cluster together. Any cells that deviate are flagged for further evaluation.
3. Filter out normal cells
ECLIPSE removes all events that overlap with the control model. This eliminates noise and leaves a highly focused set of potentially abnormal cells.
4. Visualize remaining cells with PCA
Principal Component Analysis (PCA) is applied to the filtered data. The result is a simplified 2D map that shows only the abnormal populations, with marker loadings indicating which markers drive the separation.
5. Deliver a clean, reproducible output
The final view includes only the diagnostically relevant cells. Because ECLIPSE is deterministic, the same sample will always produce the same result, supporting reproducibility, clinical review, and auditability.
Frequently asked questions
Can Asudes be used for clinical diagnostics?
While Asudes provides important insights and data analysis, it is designed to support decision-making in clinical research and patient care.
Decision support platforms are essential in both research and clinical settings within the field of flow cytometry. They equip researchers and clinicians with necessary tools and resources.
This platform make the analysis and interpretation of flow cytometry data easier. As a result, they enable users to extract meaningful insights from complex datasets.
How can I access the Asudes platform?
Asudes is accessible as a cloud-based service, ensuring convenient access worldwide. For subscription details and how to integrate asudes into your operations, we encourage potential users to book a free meeting for all of the upcoming updates.
Is training provided for new users of Asudes?
Yes, training and support will be provided for all new users by our clinical scientist and application specialist of Asudes. We will ensure you can fully use the platform’s capabilities. It includes dedicated resources for training and ongoing support post-launch.
What is the cost of using Asudes?
The pricing model for Asudes will be subscription-based. Our pricing model involves a subscription fee per clinical indication, which enables access to our decision support platform customized to specific medical indications.
There is a one-time setup fee covering initial customization and configuration. For Contract Research Organizations (CROs), we offer custom pricing models customized to their unique needs and usage patterns.
How does FlowView Diagnostics ensure data privacy and security?
At FlowView Diagnostics, making sure the privacy and security of your data is the most important to us. We take data security very seriously and stick strictly to GDPR regulations to protect personal information.
Our thorough approach includes strong encryption methods, access controls, and regular audits to protect data integrity. We also implement stringent privacy policies and provide user-friendly mechanisms for data management.
Can Asudes integrate with existing flow cytometry equipment?
Yes, asudes is being developed to ensure compatibility with a broad range of flow cytometry equipment via API’s. It allows seamless integration and processing of data from various instruments. This flexibility makes Asudes a versatile tool for better flow cytometry analysis across different platforms.
Who can benefit from using FlowView Diagnostics' solutions?
Upon its launch in April 2024, healthcare professionals, clinical researchers, medical schools, research institutes, and Clinical Research Organizations (CROs) can find great value in our AI-driven solutions.
Asudes is designed for anyone seeking to streamline complex data analysis and improve decision-making processes in the realm of flow cytometry.
Still unsure? Book a free meeting with our specialist.
Get all the upcoming updates about Asudes into your inbox.
You may unsubscribe anytime. View our privacy policy for more.
